UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 000-55281

 

Lotus Bio-Technology Development Corp.

 

(Exact name of registrant as specified in its charter)

 

108 2559 Parkview Lane Port Coquitlam BC V3C6M1

 

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common, par value .0001

 

(Title of each class of securities covered by this Form)

 

 

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

  Rule 12g-4(a)(1) ☒   
  Rule 12g-4(a)(2) ☐   
  Rule 12h-3(b)(1)(i) ☐   
  Rule 12h-3(b)(1)(ii) ☐   
  Rule 15d-6 ☐   
  Rule 15d-22(b) ☐   

 

Approximate number of holders of record as of the certification or notice date: 150

 

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: Jun 9/2021   By: Zoltan Nagy President

 

Instruction: This form is required by Rules 12g-4, 12h-3, 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.

 

SEC 2069 (08-11) Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.

 

Grafico Azioni Lotus Bio Technology Dev... (CE) (USOTC:LBTD)
Storico
Da Dic 2024 a Gen 2025 Clicca qui per i Grafici di Lotus Bio Technology Dev... (CE)
Grafico Azioni Lotus Bio Technology Dev... (CE) (USOTC:LBTD)
Storico
Da Gen 2024 a Gen 2025 Clicca qui per i Grafici di Lotus Bio Technology Dev... (CE)